Login / Signup

Single agent efficacy of the HDAC inhibitor DATS in preclinical models of glioblastoma.

Arabinda DasFraser HendersonStephen LoweGerald C WallaceWilliam A VandergriftScott M LindhorstAbhay K VarmaLibby K InfingerPierre GiglioNarendra L BanikSunil J PatelDavid Cachia
Published in: Cancer chemotherapy and pharmacology (2018)
DATS may be an effective and well-tolerated therapeutic agent in preventing tumor progression and inducing apoptosis in human GB.
Keyphrases